lvrachЛечащий ВрачLechaschi Vrach1560-51752687-1181lvrach-549Research ArticleСтатьиГипопаратиреоз в детском и подростковом возрастеHypoparathyroidism in children and adolescents (part 2)СмирновВ. В.SmirnovV. V.smirnov-web@mail.ruВладимироваП. Н.VladimirovaP. N.noemail@neicon.ruГБОУ ВПО РНИМУ им. Н. И. Пирогова МЗ РФRussian Federation201823062021075252Copyright © Смирнов В.В., Владимирова П.Н., 20212021Смирнов В.В., Владимирова П.Н.Smirnov V.V., Vladimirova P.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/549

В статье рассмотрены современные данные о этиологии, патогенезе, клинике, генетической диагностике гипопаратиреоза у детей-подростков. Описаны синдромы, протекающие с клиникой этого заболевания. Представлены методы обследования и современные рекомендации по лечению.

The article considers modern data on etiology, pathogenesis, clinical picture, genetic diagnostics of hypoparathyroidism in adolescents and children. The syndromes flowing with the clinical picture of this disease are described. The methods of examination and modern recommendations for treatment are presented. 

Страничка педиатраГипопаратиреозПаратгормонГипокальциемияТетанияГенетическая диагностикаВитамин DДетиПодросткиhypoparathyroidismparathyroid hormonehypocalcemiatetanygenetic diagnosticsvitamin DchildrenadolescentsReferencesБалаболкин М. И., Клебанова Е. М., Креминская В. М. Дифференциальная диагностика и лечение эндокринных заболеваний (руководство). М.: Медицина, 2002. 751 с.Балаболкин М. И., Клебанова Е. М., Креминская В. М. Дифференциальная диагностика и лечение эндокринных заболеваний (руководство). М.: Медицина, 2002. 751 с.Chen R. A., Goodman W. G. Role of the calcium-sensing receptor in parathyroid gland physiology // American journal of physiology — renal physiology. 2004; 286 (6): 1005–1011. DOI: 10.1152/ajprenal.00013.2004.Chen R. A., Goodman W. G. Role of the calcium-sensing receptor in parathyroid gland physiology // American journal of physiology — renal physiology. 2004; 286 (6): 1005–1011. DOI: 10.1152/ajprenal.00013.2004.Почечная эндокринология / Под ред. М. Дж. Дана. Пер. с англ. В. И. Кондора. М.: Медицина, 1987. 672 с.Почечная эндокринология / Под ред. М. Дж. Дана. Пер. с англ. В. И. Кондора. М.: Медицина, 1987. 672 с.Зиновьев В. Н., Иежица И. Н., Спасов А. А. Гомеостаз магния: механизмы и наследственные нарушения // Биомедицинская химия. 2007, т. 53, вып. 6, с. 683–704.Зиновьев В. Н., Иежица И. Н., Спасов А. А. Гомеостаз магния: механизмы и наследственные нарушения // Биомедицинская химия. 2007, т. 53, вып. 6, с. 683–704.Forman J. P., Giovannucci E., Holmes M. D. et al. Plasma 25-hydroxyvitamin D level and risk of incidents hypertension // Hypertension. 2007. Vol. 49. P. 1063–1069.Forman J. P., Giovannucci E., Holmes M. D. et al. Plasma 25-hydroxyvitamin D level and risk of incidents hypertension // Hypertension. 2007. Vol. 49. P. 1063–1069.Патофизиология / Под ред. чл.-кор. РАМН, проф. Г. В. Порядина. М., 2014.Патофизиология / Под ред. чл.-кор. РАМН, проф. Г. В. Порядина. М., 2014.Орлова Е. М., Созаева Л. С., Маказан Н. В. Гипопаратиреоз у детей: клинические варианты, современная диагностика и лечение (лекция для врачей) // Доктор.Ру. 2014. Т. 11. № 99. С. 27–30.Орлова Е. М., Созаева Л. С., Маказан Н. В. Гипопаратиреоз у детей: клинические варианты, современная диагностика и лечение (лекция для врачей) // Доктор.Ру. 2014. Т. 11. № 99. С. 27–30.Дедов И. И., Петеркова В. А. Справочник детского эндокринолога. Литтерра, 2014. 528 с.Дедов И. И., Петеркова В. А. Справочник детского эндокринолога. Литтерра, 2014. 528 с.Li D., Opas E. E., Tuluc F., Metzger D. L., Hou C., Hakonarson H. et al. Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization // J Clin Endocrinol Metab. 2014; 99: E177483.Li D., Opas E. E., Tuluc F., Metzger D. L., Hou C., Hakonarson H. et al. Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization // J Clin Endocrinol Metab. 2014; 99: E177483.Betterl C., Garelli S., Presotto F. Diagnosis and classification of autoimmune parathyroid disease // Autoimmunity Reviews. 2014. 13. 417–422.Betterl C., Garelli S., Presotto F. Diagnosis and classification of autoimmune parathyroid disease // Autoimmunity Reviews. 2014. 13. 417–422.Lima K., Abrahamsen T. G., Wol? A. B., Husebye E., Alimohammadi M., Kampe O. et al. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome // European Journal of Endocrinology. 2011; 165 (2): 345–352. DOI: 10.1530/eje-10–1206.Lima K., Abrahamsen T. G., Wol? A. B., Husebye E., Alimohammadi M., Kampe O. et al. Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome // European Journal of Endocrinology. 2011; 165 (2): 345–352. DOI: 10.1530/eje-10–1206.Husebye E. S., Perheentupa J., Rautemaa R., K?mpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I // J Intern Med. 2009; 265 (5): 51429. DOI: 10.1111/j.1365–2796.2009.02090.x12.Husebye E. S., Perheentupa J., Rautemaa R., K?mpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I // J Intern Med. 2009; 265 (5): 51429. DOI: 10.1111/j.1365–2796.2009.02090.x12.Garrahy A., Murphy M. S., Sheahan P. Impact of postoperative magnesium levels on early hypocalcemia and permanent hypoparathyroidism after thyroidectomy // HeadNeck. 2016, 38 (4): 613–619. DOI: 10.1002/hed.23937.Garrahy A., Murphy M. S., Sheahan P. Impact of postoperative magnesium levels on early hypocalcemia and permanent hypoparathyroidism after thyroidectomy // HeadNeck. 2016, 38 (4): 613–619. DOI: 10.1002/hed.23937.Stack B. C. Jr., Bimston D. N., Bodenner D. L., Brett E. M., Dralle H., Orloff L. A. et al. American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: postoperative hypoparathyroidism — definitions and management // Endocr Pract. 2015, 21 (6): 674–685. DOI: 10.4158/ep14462.dsc.Stack B. C. Jr., Bimston D. N., Bodenner D. L., Brett E. M., Dralle H., Orloff L. A. et al. American Association of Clinical Endocrinologists and American College of Endocrinology Disease state clinical review: postoperative hypoparathyroidism — definitions and management // Endocr Pract. 2015, 21 (6): 674–685. DOI: 10.4158/ep14462.dsc.Ди-Джорджи Donna M., McDonald-McGinn, Kathleen E. Sullivan, Bruno Marino, Nicole Philip, Ann Swillen, Jacob A. S. et al. 22 q11.2 deletion syndrome // Nat Rev Dis Primers. 2015; 1: 15071. DOI: 10.1038/nrdp.2015.71.Ди-Джорджи Donna M., McDonald-McGinn, Kathleen E. Sullivan, Bruno Marino, Nicole Philip, Ann Swillen, Jacob A. S. et al. 22 q11.2 deletion syndrome // Nat Rev Dis Primers. 2015; 1: 15071. DOI: 10.1038/nrdp.2015.71.Yuichi Hayashi, Tetsuya Suwa, Takashi Inuzuka. Intracranial Calcification in a Patient with HDR Syndrome and a GATA3 Mutation // Intern Med. 2013, 52: 161–162. DOI: 10.2169/internalmedicine.52.8911.Yuichi Hayashi, Tetsuya Suwa, Takashi Inuzuka. Intracranial Calcification in a Patient with HDR Syndrome and a GATA3 Mutation // Intern Med. 2013, 52: 161–162. DOI: 10.2169/internalmedicine.52.8911.Tony E. L. Jabbour, Tarek Aboursheid, Mohammad Baraa Keifo,? Ismael Maksoud, Diana Alasmar. Kenny-Caffey syndrome type 1 // Avicenna Journal of Medicine. Vol. 4, № 3. P. 74–76. DOI: 10.4103/2231–0770.133340.Tony E. L. Jabbour, Tarek Aboursheid, Mohammad Baraa Keifo,? Ismael Maksoud, Diana Alasmar. Kenny-Caffey syndrome type 1 // Avicenna Journal of Medicine. Vol. 4, № 3. P. 74–76. DOI: 10.4103/2231–0770.133340.Tsuyoshi Isojima, Koichiro Doi, Jun Mitsui, Yoichiro Oda, Etsuro Tokuhiro et al. A recurrent de novo FAM111 A mutation causes Kenny–Caffey syndrome type 2 // Journal of Bone and Mineral Research. 2014, April, Vol. 29, № 4, p. 992–998. DOI: 10.1002/jbmr.2091.Tsuyoshi Isojima, Koichiro Doi, Jun Mitsui, Yoichiro Oda, Etsuro Tokuhiro et al. A recurrent de novo FAM111 A mutation causes Kenny–Caffey syndrome type 2 // Journal of Bone and Mineral Research. 2014, April, Vol. 29, № 4, p. 992–998. DOI: 10.1002/jbmr.2091.Kalenahalli Jagadish Kumar, Halasahalli Chowdegowda Krishna Kumar, Vadambal Gopalakrishna Manjunath, Sangaraju Mamatha. Hypoparathyroidism-retardation-dysmorphism syndrome // Indian J Hum Genet. 2013, Jul-Sep; 19 (3): 363–365. DOI: 10.4103/0971–6866.120814.Kalenahalli Jagadish Kumar, Halasahalli Chowdegowda Krishna Kumar, Vadambal Gopalakrishna Manjunath, Sangaraju Mamatha. Hypoparathyroidism-retardation-dysmorphism syndrome // Indian J Hum Genet. 2013, Jul-Sep; 19 (3): 363–365. DOI: 10.4103/0971–6866.120814.Студеникин В. М., Глоба О. В. Митохондриальная патология у детей // Лечащий Врач. 2016, № 1, с. 32–35.Студеникин В. М., Глоба О. В. Митохондриальная патология у детей // Лечащий Врач. 2016, № 1, с. 32–35.Iman S. Al-Gadi, Richard H. Haas, Marni J. Falk, Amy Goldstein, Shana E. McCormack. Endocrine Disorders in Primary Mitochondrial Disease // Journal of the Endocrine Society. 2018, April, Vol. 2, Iss. 4. P. 361–373. DOI: 10.1210/js.2017–00434.Iman S. Al-Gadi, Richard H. Haas, Marni J. Falk, Amy Goldstein, Shana E. McCormack. Endocrine Disorders in Primary Mitochondrial Disease // Journal of the Endocrine Society. 2018, April, Vol. 2, Iss. 4. P. 361–373. DOI: 10.1210/js.2017–00434.Shemesh A., Margolin E. Kearns Sayre Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018, Jan.Shemesh A., Margolin E. Kearns Sayre Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018, Jan.Rude R. K., Oldham S. B., Singer F. R. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency // Clin Endocrinol (Oxf). 1976, 5 (3): 209–224. DOI: 10.1111/j.1365–2265.1976. tb01947.x.Rude R. K., Oldham S. B., Singer F. R. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency // Clin Endocrinol (Oxf). 1976, 5 (3): 209–224. DOI: 10.1111/j.1365–2265.1976. tb01947.x.Aguespack S. G. W., Koller D. L., White K. E., Fishburn T., Carn G., Buckwalter K. A. et al. Chloride channel 7 (CLCN7) gene mutations and autosomal dominant osteopetrosis, Type II // J Bone Min Res 2003; 18: 1513–1518.Aguespack S. G. W., Koller D. L., White K. E., Fishburn T., Carn G., Buckwalter K. A. et al. Chloride channel 7 (CLCN7) gene mutations and autosomal dominant osteopetrosis, Type II // J Bone Min Res 2003; 18: 1513–1518.Phelan M. C., Rogers R. C., Clarkson K. B. et al. Albright hereditary osteodystrophy and del (2) (q37.3) in four unrelated individuals // Am J Med Genet. 1995; 58: 1: 1–7.Phelan M. C., Rogers R. C., Clarkson K. B. et al. Albright hereditary osteodystrophy and del (2) (q37.3) in four unrelated individuals // Am J Med Genet. 1995; 58: 1: 1–7.Mantovani G., Spada A. Mutations in the gs alpha gene causing hormone resistance // Best Practice & Research Clinical Endocrinology & Metabolism. 2006; 20 (4): 501–513.Mantovani G., Spada A. Mutations in the gs alpha gene causing hormone resistance // Best Practice & Research Clinical Endocrinology & Metabolism. 2006; 20 (4): 501–513.Farfel Z., Brickman A. S., Kaslow H. R. et al. Defect of Receptor– Cyclase Coupling Protein in Pseudohypoparathyroidism // N Engl J Med. 1980; 303 (5): 237–242. DOI: 10.1056/nejm198007313030501.Farfel Z., Brickman A. S., Kaslow H. R. et al. Defect of Receptor– Cyclase Coupling Protein in Pseudohypoparathyroidism // N Engl J Med. 1980; 303 (5): 237–242. DOI: 10.1056/nejm198007313030501.Albright F., Burnett C. H., Smith P. H., Parsons W. Pseudoparathyroidism — an example of the Seabright-Bantam syndrome. Report of 3 cases // Endocrinology. 1942; 30: 922–993.Albright F., Burnett C. H., Smith P. H., Parsons W. Pseudoparathyroidism — an example of the Seabright-Bantam syndrome. Report of 3 cases // Endocrinology. 1942; 30: 922–993.Маказан Н. В., Орлова Е. М., Карева М. А. Псевдогипопаратиреоз // Проблемы эндокринологии. 2015, 3, с. 47–55. DOI: 10.14341/probl201561347–56.Маказан Н. В., Орлова Е. М., Карева М. А. Псевдогипопаратиреоз // Проблемы эндокринологии. 2015, 3, с. 47–55. DOI: 10.14341/probl201561347–56.Hadker N., Egan J., Sanders J., Lagast H., Clarke B. L. Understanding the burden of illness associated with hypoparathyroidism reported among patients in the paradox study // Endocr Pract. 2014, 20 (7): 671–679. DOI: 10.4158/ep13328.or.Hadker N., Egan J., Sanders J., Lagast H., Clarke B. L. Understanding the burden of illness associated with hypoparathyroidism reported among patients in the paradox study // Endocr Pract. 2014, 20 (7): 671–679. DOI: 10.4158/ep13328.or.Allgrove J., Shaw N. Calcium and Bone Disorders in Children and Adolescents Endocrine Development. NY: S. Karger Pub., 2009. P. 73–92.Allgrove J., Shaw N. Calcium and Bone Disorders in Children and Adolescents Endocrine Development. NY: S. Karger Pub., 2009. P. 73–92.Abate E. G., Clarke B. L. Review of hypoparathyroidism // Front Endocrinol (Lausanne). 2016; 7: 172. DOI: 10.3389/fendo.2016.00172.Abate E. G., Clarke B. L. Review of hypoparathyroidism // Front Endocrinol (Lausanne). 2016; 7: 172. DOI: 10.3389/fendo.2016.00172.Levy I., Licht C., Daneman A., Sochett E., Harrington J. The impact of hypoparathyroidism treatment on the kidney in children: long term retrospective follow up study // J Clin Endocrinol Metab. 2015, 100 (11): 4106–4113. DOI: 10.1210/jc.2015–2257.Levy I., Licht C., Daneman A., Sochett E., Harrington J. The impact of hypoparathyroidism treatment on the kidney in children: long term retrospective follow up study // J Clin Endocrinol Metab. 2015, 100 (11): 4106–4113. DOI: 10.1210/jc.2015–2257.Ejigayehu G. Abate, Bart L. Clarke. Review of Hypoparathyroidism Ejigayehu // Front. Endocrinol. 16 January 2017. https://doi.org/10.3389/fendo.2016.00172.Ejigayehu G. Abate, Bart L. Clarke. Review of Hypoparathyroidism Ejigayehu // Front. Endocrinol. 16 January 2017. https://doi.org/10.3389/fendo.2016.00172.Орлова Е. М. Федеральные клинические рекомендации по диагностике и лечению гипопаратиреоза у детей и подростков // Проблемы эндокринологии. 2014, 3, с. 69–74. DOI: 10.14341/probl201460369–74.Орлова Е. М. Федеральные клинические рекомендации по диагностике и лечению гипопаратиреоза у детей и подростков // Проблемы эндокринологии. 2014, 3, с. 69–74. DOI: 10.14341/probl201460369–74.Heaney R. P. Vitamin D in Health and Disease // Clin J Am Sac Nephro. 2008. 13: 1535–1541.Heaney R. P. Vitamin D in Health and Disease // Clin J Am Sac Nephro. 2008. 13: 1535–1541.Bollerslev J., Rejnmark L., Marcocci C., Shoback D. M., Sitges-Serra A., van Biesen W. et al. European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults // Eur J Endocrinol. 2015, 173 (2): G1–20. DOI: 10.1530/eje-15–0628.Bollerslev J., Rejnmark L., Marcocci C., Shoback D. M., Sitges-Serra A., van Biesen W. et al. European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults // Eur J Endocrinol. 2015, 173 (2): G1–20. DOI: 10.1530/eje-15–0628.Garrahy A., Murphy M. S., Sheahan P. Impact of postoperative magnesium levels on early hypocalcemia and permanent hypoparathyroidism after thyroidectomy // HeadNeck. 2016, 38 (4): 613–619. DOI: 10.1002/hed.23937.Garrahy A., Murphy M. S., Sheahan P. Impact of postoperative magnesium levels on early hypocalcemia and permanent hypoparathyroidism after thyroidectomy // HeadNeck. 2016, 38 (4): 613–619. DOI: 10.1002/hed.23937.Gemma Marcucci, Giuseppe Della Pepa, Maria Luisa Brand. Natpara for the treatment of hypoparathyroidism // Expert opinion on biological therapy. 2016. Vol. 16, № 11, 1417–1424. http://dx.doi.org/10.1080/14712598.2016.1238455.Gemma Marcucci, Giuseppe Della Pepa, Maria Luisa Brand. Natpara for the treatment of hypoparathyroidism // Expert opinion on biological therapy. 2016. Vol. 16, № 11, 1417–1424. http://dx.doi.org/10.1080/14712598.2016.1238455.Clarke B. L., Kay Berg J., Fox J., Cyran J. A., Lagast H. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1–84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study // Clin Ther. 2014, 36 (5): 722–736. DOI: 10.1016/j.clinthera.2014.04.001).Clarke B. L., Kay Berg J., Fox J., Cyran J. A., Lagast H. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1–84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study // Clin Ther. 2014, 36 (5): 722–736. DOI: 10.1016/j.clinthera.2014.04.001).

The authors declare that there are no conflicts of interest present.